STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
AcquisitionsApr 23, 2026, 08:58 AM

DAWN: Servier Tender Offer Expires, 85.34% Shares Acquired

AI Summary

Servier's cash tender offer to acquire Day One Biopharmaceuticals, Inc. expired on April 22, 2026. A significant majority of shares, totaling 88,180,910 and representing approximately 85.34% of Day One's outstanding common stock, were validly tendered at $21.50 per share. This successful tender offer indicates the acquisition by Servier is proceeding as planned.

Key Highlights

  • Servier's tender offer for Day One Biopharmaceuticals expired on April 22, 2026.
  • A total of 88,180,910 shares were validly tendered.
  • This represents approximately 85.34% of outstanding shares.
  • The offer price was $21.50 per share.
DAWN
Biotechnology: Pharmaceutical Preparations
Day One Biopharmaceuticals, Inc.

Price Impact